What they were paid
Whitehawk Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $55,000 | $0 | $57,968 | $0 | $112,968 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Whitehawk Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-187149, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Whitehawk Therapeutics pays directors a $40,000 cash retainer and $58,000 in Options.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance (Chair)
The rest of the Whitehawk Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Baiteng Zhao, M.D | Independent Director | $97,968 |
| Behzad Aghazadeh, Ph.D | Independent Director | $102,468 |
| Caley Castelein, M.D | Independent Director | $137,968 |
| David Lennon, Ph.D | Director | $0 |
| Emma Reeve | Independent Director | $117,968 |
| Karin Hehenberger, M.D., Ph.D | Director | $22,250 |
| Mohammad Hirmand, M.D | Independent Director | $97,968 |
| Neil Desai, Ph.D | Director | $97,968 |
| Richard Maroun | Independent Director | $117,968 |
The full Whitehawk Therapeutics compensation record
free company briefThis page is one director within Whitehawk Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat